http://venturebeat.com/2007/06/12/arca-discovery-raises-18m-for-cardiovascular-drug/ News About Tech, Money and Innovation Mon, 23 Nov 2009 07:11:08 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/06/12/arca-discovery-raises-18m-for-cardiovascular-drug/comment-page-1/#comment-450172 VentureBeat » Personalized medicine takes a (tiny) step forward Thu, 16 Aug 2007 19:42:34 +0000 http://venturebeat.com/2007/06/12/arca-discovery-raises-18m-for-cardiovascular-drug/#comment-450172 [...] So far, however, there aren’t too many other similar personalized treatments out there, or even in development. One exception is the beta blocker bucindolol being developed by Arca Discovery, which aims to test the drug in patients who have specific genetic variants; I wrote about them here. [...] [...] So far, however, there aren’t too many other similar personalized treatments out there, or even in development. One exception is the beta blocker bucindolol being developed by Arca Discovery, which aims to test the drug in patients who have specific genetic variants; I wrote about them here. [...]

]]> http://venturebeat.com/2007/06/12/arca-discovery-raises-18m-for-cardiovascular-drug/comment-page-1/#comment-450158 VentureBeat » Personalized medicine takes a (tiny) step forward Thu, 16 Aug 2007 19:42:33 +0000 http://venturebeat.com/2007/06/12/arca-discovery-raises-18m-for-cardiovascular-drug/#comment-450158 [...] So far, however, there aren’t too many other similar personalized treatments out there, or even in development. One exception is the beta blocker bucindolol being developed by Arca Discovery, which aims to test the drug in patients who have specific genetic variants; I wrote about them here. [...] [...] So far, however, there aren’t too many other similar personalized treatments out there, or even in development. One exception is the beta blocker bucindolol being developed by Arca Discovery, which aims to test the drug in patients who have specific genetic variants; I wrote about them here. [...]

]]>